While MAP17 levels are typically increased in tumor samples compared to levels in non-tumoral samples, no changes in the expression of TAL1 have been observed, showing that, at least in cancer cells, MAP17 transcription is independent [31]. The gene discussed is PDZK1IP1; the disease is neoplasm.